The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environment

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  1991-04-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/BF01966996PMID 1713846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase.

  1991cited by this paper
• Potential mechanisms of resistance to the modern fluorinated 4-quinolones.

  1990cited by this paper
• DNA breakdown by the 4-quinolones and its significance.

  1990cited by this paper
• Electrochemical characteristics of five quinolone drugs and their effect on DNA damage and repair in Escherichia coli.

  1990cited by this paper
• The Influence of Oxygen upon Bactericidal Potency

  1990cited by this paper
• The accumulation of five quinolone antibacterial agents by Escherichia coli.

  1990cited by this paper
• Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.

  1990cited by this paper
• In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria

  1990cited by this paper
• Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens.

  1990cited by this paper
• In vitro activities of irloxacin and E-3846, two new quinolones

  1990cited by this paper
• Mechanisms of resistance to quinolones and clinical perspectives.

  1989influential reference
• Bactericidal activity of enoxacin and Lomefloxacin againstEscherichia coli KL16

  1989cited by this paper
• In vitro activity of AT-4140 against clinical bacterial isolates

  1989cited by this paper
• 4-quinolones and the SOS response.

  1989cited by this paper
• Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers

  1989cited by this paper
• The bactericidal activity of DR-3355, an optically active isomer of ofloxacin.

  1989cited by this paper
• The effect of mutations in the SOS response on the kinetics of quinolone killing.

  1989cited by this paper
• Inhibition of enoxacin absorption by antacids or ranitidine

  1989cited by this paper
• An overlap between osmotic and anaerobic stress responses: a potential role for DNA supercoiling in the coordinate regulation of gene expression

  1989cited by this paper
• Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.

  1989cited by this paper
• Routes of quinolone permeation in Escherichia coli

  1988cited by this paper
• 2 – Chemistry and Mechanisms of Action of the Quinolone Antibacterials

  1988cited by this paper
• Bactericidal mechanisms of ofloxacin.

  1988cited by this paper
• In vitro activity of PD 127,391, an enhanced-spectrum quinolone

  1988cited by this paper
• Bactrecidal mechanisms of ofloxacin

  1988cited by this paper
• DNA supercoiling and the anaerobic and growth phase regulation of tonB gene expression

  1988cited by this paper
• Inhibitors of DNA topoisomerases.

  1988cited by this paper
• A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli.

  1988cited by this paper
• Bacterial mutagenicity and the 4-quinolones.

  1987cited by this paper
• Induction of the SOS response by new 4-quinolones.

  1987cited by this paper
• Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis

  1987cited by this paper
• Accumulation of enoxacin by Escherichia coli and Bacillus subtilis

  1987cited by this paper
• Effect of oral ofloxacin on fecal bacteria in human volunteers

  1987cited by this paper
• Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody.

  1987cited by this paper
• Mechanisms of action of and resistance to ciprofloxacin.

  1987cited by this paper
• Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli.

  1987cited by this paper
• Ciprofloxacin and antacids.

  1986cited by this paper
• Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli

  1986cited by this paper
• In vitro studies of S-25930 and S-25932, two new 4-quinolones

  1986cited by this paper
• Ciprofloxacin: an overview of adverse experiences.

  1986cited by this paper
• Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12

  1986cited by this paper
• Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora

  1986cited by this paper
• Randomized evaluation of ceftazidime or ticarcillin and tobramycin for the treatment of osteomyelitis caused by gram-negative bacilli

  1986cited by this paper
• Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin.

  1986cited by this paper
• Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli

  1986cited by this paper
• Mechanisms determining aerobic or anaerobic growth in the facultative anaerobe Salmonella typhimurium.

  1985cited by this paper
• Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions

  1985cited by this paper
• DNA topoisomerases.

  1985cited by this paper
• Reduced enteral absorption of ciprofloxacin in the presence of antacids

  1985cited by this paper
• Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

  1985cited by this paper
• Interaction of Aminoglycosides and Ciprofloxacin with Bacterial Membranes

  1985cited by this paper
• NORFLOXACIN HAS A NOVEL BACTERICIDAL MECHANISM UNRELATED TO THAT OF OTHER 4‐QUINOLONES

  1985cited by this paper
• The in vitro and in vivo activity of ciprofloxacin

  1984cited by this paper
• Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

  1984cited by this paper
• Investigations into the mechanism of action of the antibacterial agent norfloxacin.

  1984cited by this paper
• In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

  1983cited by this paper
• Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptake

  1983cited by this paper
• Gentamicin Uptake in Wild-Type and Aminoglycoside-Resistant Small-Colony Mutants of Staphylococcus aureus

  1980cited by this paper
• Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid

  1978cited by this paper
• Streptomycin Accumulation in Susceptible and Resistant Strains of Escherichia coli and Pseudomonas aeruginosa

  1976cited by this paper
• Nalidixic Acid: an Antibacterial Paradox

  1975cited by this paper
• Dihydrostreptomycin accumulation in E. coli

  1974cited by this paper
• Interactions between twisted DNAs and enzymes: the effects of superhelical turns.

  1974cited by this paper
• Mechanism of Action of Nalidixic Acid on Escherichia coli III. Conditions Required for Lethality

  1966cited by this paper
• Mechanism of Action of Nalidixic Acid on Escherichia coli IV. Effects on the Stability of Cellular Constituents

  1966cited by this paper
• MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI

  1964cited by this paper
• 1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

  1962cited by this paper
• Uptake of 14C-streptomycin by some microorganisms and its relation to their streptomycin sensitivity.

  1962cited by this paper

• Interactions within higher-order antibiotic combinations do not influence the rate of adaptation in bacteria

  2025cites this paper
• Biphasic bactericidal activity of nitroxoline against Acinetobacter baumannii assessed by Raman-DIP.

  2025cites this paper
• Biphasic bactericidal activity of nitroxoline against Acinetobacter baumannii isolates from urinary tract infections

  2025cites this paper
• Effect of H2S and cysteine homeostasis disturbance on ciprofloxacin sensitivity of Escherichia coli in cystine-free and cystine-fed minimal medium

  2024cites this paper
• Interference of gastrointestinal barriers with antibiotic susceptibility of foodborne pathogens: an in vitro case study of ciprofloxacin and tetracycline against Salmonella enterica and Listeria monocytogenes.

  2024cites this paper
• Inoculum-Based Dosing: A Novel Concept for Combining Time with Concentration-Dependent Antibiotics to Optimize Clinical and Microbiological Outcomes in Severe Gram Negative Sepsis

  2023cites this paper
• Influence of Growth Medium Composition on Physiological Responses of Escherichia coli to the Action of Chloramphenicol and Ciprofloxacin

  2023cites this paper
• Antimicrobial Activities of Ganoderma mbrekobenum Strain EGDA (Agaricomycetes) from Egypt.

  2023cites this paper
• Bio-Enhanced Degradation Strategies for Fluoroquinolones in the Sewage Sludge Composting Stage: Molecular Modification and Resistance Gene Regulation

  2022cites this paper
• VIRIAL INFECTIONS: REPLICATION AND PATHOGENESIS MECHANISMS TO THERAPY Enhancement of the Bactericidal Effect of Antibiotics by Inhibition of Enzymes Involved in Production of Hydrogen Sulfide in Bacteria

  2022cites this paper
• Study of the early response of Escherichia coli lpcA and ompF mutants to ciprofloxacin.

  2022cites this paper
• Study of the contribution of active defense mechanisms to ciprofloxacin tolerance in Escherichia coli growing at different rates

  2021influential citation
• A data-based mathematical modelling study to quantify the effects of ciprofloxacin and ampicillin on the within-host dynamics of Salmonella enterica during treatment and relapse

  2020cites this paper
• Antimicrobial Resistance, Gut Microbiota, and Health

  2019cites this paper
• In vitro influence of metronidazole on the activities of ciprofloxacin against clinically important bacterial isolates

  2019cites this paper
• Relationship between Escherichia coli growth rate and bacterial susceptibility to ciprofloxacin

  2018cites this paper
• Heterogeneity of Salmonella-host interactions 1 in infected host tissues 2 3

  2018cites this paper
• Suppression of Reactive Oxygen Species Accumulation Accounts for Paradoxical Bacterial Survival at High Quinolone Concentration

  2017cites this paper
• Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.

  2017cites this paper
• Ciprofloxacin provokes SOS-dependent changes in respiration and membrane potential and causes alterations in the redox status of Escherichia coli.

  2017influential citation
• Heterogeneity of Salmonella-host interactions in infected host tissues.

  2017cites this paper
• Understanding and Sensitizing Density-Dependent Persistence to Quinolone Antibiotics.

  2017influential citation
• Pharmacodynamics of Fluoroquinolones

  2016cites this paper
• Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli

  2016cites this paper
• Eagle Effect in Nonreplicating Persister Mycobacteria

  2015cites this paper
• Non-Monotonic Survival of Staphylococcus aureus with Respect to Ciprofloxacin Concentration Arises from Prophage-Dependent Killing of Persisters

  2015cites this paper
• A mechanism-based pharmacokinetic/pharmacodynamic model allows prediction of antibiotic killing from MIC values for WT and mutants.

  2015cites this paper
• Synergistic Effects Between Thioxanthones and Oxacillin Against Methicillin-Resistant Staphylococcus aureus

  2015cites this paper
• Unraveling the physiological complexities of antibiotic lethality.

  2015cites this paper
• Reactive oxygen species and the bacterial response to lethal stress.

  2014cites this paper
• Ribosomal Elongation Factor 4 Promotes Cell Death Associated with Lethal Stress

  2014cites this paper
• Effect of pH on the in vitro susceptibility of planktonic and biofilm‐grown Proteus mirabilis to the quinolone antimicrobials

  2013cites this paper
• A Screen for and Validation of Prodrug Antimicrobials

  2013cites this paper
• Screening for broad spectrum antimicrobials with unknown targets

  2013cites this paper
• Programming stress-induced altruistic death in engineered bacteria

  2012cites this paper
• Quinolone Mode of Action — New Aspects

  2012influential citation
• Inferring Dynamic Signatures of Microbes in Complex Host Ecosystems

  2012cites this paper
• Bacterial Infections in the Elderly Patient: Focus on Sitafloxacin

  2012cites this paper
• An initial screening of antibiotic effects on microbial respiration in wetland soils

  2012cites this paper
• Comparative study of antibacterial activity of wood-decay fungi and antibiotics

  2011cites this paper
• Pharmacodynamic Modeling of In Vitro Activity of Marbofloxacin against Escherichia coli Strains

  2010cites this paper
• High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.

  2009cites this paper
• Functional relationship between bacterial cell density and the efficacy of antibiotics.

  2009cites this paper
• Drug interactions and the evolution of antibiotic resistance

  2009cites this paper
• Antibiotic Resistance of Anaerobic Bacteria

  2009cites this paper
• Infection Staphylococcal Experimental Foreign-Body Efficacy of High-Dose Levofloxacin in Antagonistic Effect of Rifampin on the

  2008cites this paper
• Antagonistic Effect of Rifampin on the Efficacy of High-Dose Levofloxacin in Staphylococcal Experimental Foreign-Body Infection

  2008cites this paper
• Effects of ciprofloxacin on salt marsh sediment microbial communities

  2007cites this paper
• Effect of Anaerobic Growth on Quinolone Lethality with Escherichia coli

  2006cites this paper
• Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.

  2006cites this paper
• Moxifloxacin Lethality against Mycobacterium tuberculosis in the Presence and Absence of Chloramphenicol

  2006cites this paper
• Entwicklung zellulärer und molekularbiologischer Testsysteme zur Bestimmung der Aktivität von Fluorchinolonen auf Typ II-Topoisomerasen am Beispiel von Pradofloxacin - einem neuen C8-Cyanofluorchinolon

  2005influential citation
• In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity.

  2004cites this paper
• Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.

  2004cites this paper
• Postantibiotic Effect and Delay of Regrowth in Strains Carrying Mutations That Save Proteins or RNA

  2002cites this paper
• Comparative Pharmacodynamics of Three Newer Fluoroquinolones versus Six Strains of Staphylococci in an In Vitro Model under Aerobic and Anaerobic Conditions

  2002cites this paper
• Mechanisms of action of antimicrobials: focus on fluoroquinolones.

  2001cites this paper
• A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.

  2001cites this paper
• Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.

  2001cites this paper
• The bactericidal activity of gemifloxacin (SB-265805).

  2000cites this paper
• Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa.

  2000cites this paper
• Accumulation of Norfloxacin byBacteroides fragilis

  2000cites this paper
• Mechanisms of Action of Quinolones against Staphylococci and Relationship with Their in vitro Bactericidal Activity

  1999cites this paper
• Bactericidal Activity and Postantibiotic Effect of Levofloxacin against Anaerobes

  1999cites this paper
• Trovafloxacin: A New Fluoroquinolone

  1999cites this paper
• Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae.

  1999cites this paper
• Levofloxacin, a Second‐Generation Fluoroquinolone

  1998cites this paper
• Bactericidal index: a new way to assess quinolone bactericidal activity in vitro.

  1997cites this paper
• The chemistry and biological profile of trovafloxacin.

  1997cites this paper
• Antimicrobial resistance in anaerobes.

  1997cites this paper
• The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.

  1997cites this paper
• DNA gyrase, topoisomerase IV, and the 4-quinolones

  1997cites this paper
• Fluoroquinolone action in mycobacteria: similarity with effects in Escherichia coli and detection by cell lysate viscosity

  1996cites this paper
• Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones

  1996cites this paper
• Bactericidal activity of trovafloxacin (CP-99,219).

  1996cites this paper
• Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa

  1995cites this paper
• Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones

  1995cites this paper
• Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.

  1995cites this paper
• Activity of 4-quinolones against Pseudomonas aeruginosa.

  1994cites this paper
• In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis

  1994cites this paper
• Antimicrobial resistance in Bacteroides.

  1993cites this paper
• Fluoroquinolones: mechanisms of action and resistance.

  1993cites this paper
• Studies on mutational cross-resistance between ciprofloxacin, novobiocin and coumermycin in Escherichia coli and Staphylococcus warneri.

  1993cites this paper
• Molecular biological characteristics of the antibacterial action of 4-quinolone-3-carboxylic acid derivatives (review)

  1993cites this paper
• Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.

  1992cites this paper
• The Role of the Fluoroquinolones

  1992cites this paper
• The Fluoroquinolones Exert a Reduced Rate of Kill Against Enterococcus faecalis

  1991cites this paper